![](https://pharma.industry-report.net/wp-content/uploads/2019/01/usfda-326x245.png.webp)
Lupin receives USFDA approval for Lurasidone Hcl tablets
Lupin has received USFDA approval to market Lurasidone Hydrochloride tablets in US markets. The drug is used in the treatment of schizophrenia and will be […]
Lupin has received USFDA approval to market Lurasidone Hydrochloride tablets in US markets. The drug is used in the treatment of schizophrenia and will be […]
Everest Organics Ltd is planning an expansion programme at its pharma unit in Aroor in Sadashivpet Mandal in Medak district of Telangana. The project involves […]
Copyright © 2025 | WordPress Theme by MH Themes